An interventional study of Proprioceptive Neuromuscular Facilitation and Local Cryotherapy in Delayed Onset Muscle Soreness (DOMS), sponsored by Universidad Pontificia de Salamanca. Completed at 1 site in Spain. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-16.
Sponsored by Universidad Pontificia de Salamanca · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 341 studies in Pain with a site in Spain — 58 open to participants now, 67 under way, 7 of them phase 3. Pain · Spain.
Among the 341 studies in Pain with a site in Spain, this one is the 251st largest by enrollment of the 295 interventional ones that give a count, is one of 24 that started in 2025, is one of 206 with no phase, and was the 332nd registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →58 of the 341 studies in Pain with a site in Spain are open now. Recruiting first, the newest first:
Neuron, Spain · Sites in Spain
Ages 18+ · Healthy volunteers
University Rovira i Virgili · Sites in Spain
Ages 18–40 · Healthy volunteers
European University Miguel de Cervantes · Sites in Spain
Ages 18+ · Women only
Institut Investigacio Sanitaria Pere Virgili · Sites in Spain
Ages 18–50 · Women only
Arafarma Group, S.A. · Sites in Spain
Ages 18+ · Women only
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
341 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 29 · Phase 3 47 · Phase 4 17
First in 2001; this study’s year is marked. 24 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 29 is below the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 60 across the 295 interventional studies, 165 across the 46 observational. Of the 246 that completed or were terminated, 37 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
72 of 341 have an industry lead sponsor. The 10 most frequent:
Universidad Pontificia de Salamanca is the lead sponsor of 10 studies on the registry; 3 are open to participants now.
Universidad Pontificia de Salamanca has 5 studies filed under Pain — fewer than ten, so there is no comparison to draw.
7 of the studies in Pain with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04299893Phase 3Bernardino Clavo, MD, PhDOzone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) | 2027-09-30 |
| NCT06948500Cardenal Herrera UniversityEffectiveness of an IVR-based Therapeutic Exercise Program With Altered Visual Feedback in Fibromyalgia Patients | 2026-12-01 |
| NCT07694141Hospital Universitario de Gran Canaria Doctor NegrínPostoperative Analgesia in Thoracic Surgery | 2026-12-31 |
| NCT05635929Mucosa Innovations, S.L.Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs. | 2027-03 |
| NCT07741864Hospital Universitario Virgen MacarenaEffectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis (MPIMS). | 2027-04-30 |
Add all 7 to your calendar (.ics) → With an account.
Among the 341 studies in Pain with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized, double-blind, single-center pilot clinical trial evaluated three interventions for delayed onset muscle soreness in the hamstring muscles.
Twenty-nine untrained adults were included. Delayed onset muscle soreness was induced using two eccentric hamstring exercises. Participants were then assigned to one of three groups: proprioceptive neuromuscular facilitation, local cryotherapy, or placebo consisting of water with sugar.
The main outcome was pressure pain threshold in the hamstring muscles. Other outcomes included knee range of motion, hamstring strength, pain intensity, perceived exertion, and blood lactate levels. Measurements were taken before the eccentric exercise, 24 hours after exercise before treatment, immediately after treatment, and 48 hours after exercise.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received a proprioceptive neuromuscular facilitation intervention targeting the hamstring muscles 24 hours after eccentric exercise-induced delayed onset muscle soreness.
Other: Proprioceptive Neuromuscular Facilitation
Participants received local cryotherapy over the hamstring muscles 24 hours after eccentric exercise-induced delayed onset muscle soreness.
Other: Local Cryotherapy
Participants received a placebo intervention consisting of water with sugar 24 hours after eccentric exercise-induced delayed onset muscle soreness.
Other: Placebo: Water With Sugar
A contract-relax-antagonist-contract proprioceptive neuromuscular facilitation technique was applied to the hamstring muscles. The protocol included isometric hamstring contraction, rest, quadriceps contraction, and passive movement into a deeper hamstring stretch. The protocol was repeated twice on each leg.
Participants were placed in prone position and an ice pack was applied over the hamstring muscles for 20 minutes. A thin cloth was placed between the ice pack and the skin to avoid direct contact.
Participants consumed 200 mL of water with 5 g of dissolved sugar after the eccentric exercise protocol.
Change in Pressure Pain Threshold in the Hamstring Muscles
Pressure pain threshold was assessed using a pressure algometer over three points of maximum pain in the hamstring muscles. Three measurements were taken and the mean value was calculated.
Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise
Change in Active Knee Range of Motion
Active knee flexion and extension range of motion were assessed using a manual goniometer.
Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise
Change in Hamstring Muscle Strength
Maximum hamstring strength was assessed using a handheld dynamometer.
Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise
Change in Pain Intensity
Pain intensity was assessed using the 11-point Numeric Pain Rating Scale. Scores range from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and therefore a worse outcome.
Time frame: Baseline, 24 hours after eccentric exercise before treatment, immediately after treatment, and 48 hours after eccentric exercise
Change in Blood Lactate Concentration
Blood lactate concentration was measured using a Lactate Edge device.
Time frame: Before exercise, immediately after exercise, and 48 hours after exercise
Perceived Exertion After Eccentric Exercise
Perceived exertion was assessed using the Modified Borg Rating of Perceived Exertion Scale after completion of the eccentric exercise protocol. Scores range from 0 to 10, where 0 indicates no exertion and 10 indicates maximal exertion. Higher scores indicate greater perceived exertion and therefore a worse outcome.
Time frame: Immediately after eccentric exercise
Plan to share: Yes — De-identified individual participant data related to the outcomes reported in the study may be shared upon reasonable request to the principal investigator. Data will only be shared for academic and research purposes, after approval by the study team, and in accordance with applicable data protection regulations.
No publications or documents are linked to this record.
Ran from Jan 2025 to primary completion in Apr 2025, 3 months.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 3 months is below that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Pontificia de Salamanca